AllergyGenDB: A literature and functional annotation-based omics database for allergic diseases.
AllergyGenDB: A literature and functional annotation-based omics database for allergic diseases.
复制标题
AllergyGenDB:基于文献和功能注释的过敏性疾病组学数据库。
DOI:
10.1111/all.14219
复制
发表时间:
2020
期刊:
影响因子:
12.4
通讯作者:
Mersha,TesfayeB
中科院分区:
文献类型:
--
作者:
Chen,Siqi;Ghandikota,Sudhir;Gautam,Yadu;Mersha,TesfayeB
Driven mostly by the recent explosion of high-throughput technologies including sequencing, genotyping, and big data analytics, a vast amount of multi-omics and functional annotation data are accumulating for allergic diseases. Yet, these resources are scattered across various databases with different formats, and conducting manual search for genes associated with allergic diseases is a formidable task. As the accumulation of biomedical literature outpaces the ability of most researchers and clinicians to stay abreast of their fields, text mining, which involves automated information extraction by searching documents for text strings and analyzing their frequency and context, is critical. Hence, a comprehensive web-based one-stop bioinformatics tool is needed to efficiently query and retrieve research findings and draw novel hypotheses to understand the unique and shared association (or co-occurrence) of allergic diseases at gene, variant or pathway level. Here we describe AllergyGenDB to systematically generated allergy associated genes (or variants) from over 28 million PubMed biomedical literature citation, and from 93,892 GWAS Catalog and dbGaP SNPs resources, 1, 2 and distill their functional annotation information from Roadmap Epigenomics, GTEx, and ENCODE data. This accomplishes three things. First, it would serve to validate experiments by demonstrating that known genes occur as predicted. Second, it would rapidly highlight which genes are supported by the literature and which genes are novel in a given context. Third, it would lead novel hypotheses for understanding the unique and shared association (or co-occurrence) of allergic diseases at gene, variant or pathway level.